MedTrace Logo

Survival Rate of Adhesively Luted Veneers

NCT03145597 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-08-22

No results posted yet for this study

Summary

The aims of this clinical study are:

To evaluate the clinical performance between indirect composite and ceramic laminate veneers:

Main interests are:

* colour stability of the restoration (digital measurement in follow up)
* failure mode of the restoration
* wear of the restoration and antagonist

Hypothesis:

* The colour stability of indirect composite restorations will not be different from the ceramic restorations.
* The indirect composite restorations will not be more prone to failure than the ceramic restorations.
* Antagonist wear and restorative material wear will be similar for both ceramic and composite.

Material and Methods The laminates will be fabricated according to a specified protocol. In order to avoid possible noticeable differences in case of distinct levels of possible discoloration, a modified split mouth design is employed where the central incisors and the symmetric other teeth receive the same type of restoration. Randomization is based on the paired teeth and it is performed using the flip of a coin for the choice of material. Evaluation will be performed at baseline and at follow-up visits annually up to 2 years.

Conditions

  • Tooth Fracture

Interventions

DEVICE

Laminate veneer of composite

Composite laminate veneers, 2-4-6 veneers per patient

DEVICE

Laminate veneer of ceramic

laminate of ceramic (Empress Esthetic, Ivoclar Vivadent), ceramic laminate veneer, 2-4-6 veneers per patient will be made.

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Marco Gresnigt, Phd · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03145597 on ClinicalTrials.gov